Prostate Cancer / 2012 / Article / Tab 1

Research Article

Intake of Grains and Dietary Fiber and Prostate Cancer Aggressiveness by Race

Table 1

Characteristics of prostate cancer cases by race.

CharacteristicAfrican Americans European Americans Difference testing

Mean age (years)61.97.864.17.80.7426
% %

 North Carolina47851.452152.5
Prostate cancer aggressivenessa<0.0001
Tumor stage0.0845
Categorized sum of Gleason score0.019
 ≥8 or 7 with (4 + 3) pattern20121.717317.5
 <7 or 7 with (3 + 4) pattern72478.381782.5
Education level<0.0001
 Graduate school/prof.degree646.921621.7
 Some college/college grad27029.141241.5
 High school grad/vo-tec30833.126927.1
 <8th grade/some high school28730.9969.7
Smoking status<0.0001
Level of physical activityb<0.0001
Use of nutritional supplements<0.0001
 1–4 days/week525.6626.2
 5+ days/week56861.139439.7
Use of NSAIDs<0.0001
Multivitamin supplementation<0.0001
Family history (first degree relative affected)0.1561
Screening history (PSA or DRE)<0.0001
Body mass index (weight (kg)/height (m2))0.001
 Under weight (<18.0)91.030.3
 Normal weight (18.0–<25.0)18019.615415.6
 Over weight (25.0–<30.0)35738.946146.7
 Obese (30.0–<40.0)32535.433534.0
 Highly obese (≥40.0)475.1333.4

aProstate cancer aggressiveness is defined as the severity of the cancer at diagnosis based on combinations of the Gleason score, morphologic stage, and PSA as follows: high aggressive: Gleason sum ≥ 8 OR PSA > 20 ng/mL OR Gleason sum ≥ 7 and stage T3c-T4c; low aggressive: Gleason sum < 7 and stage T1c-T2c and PSA < 10 ng/mL; intermediate aggressive: all other cases.
bPhysical activity categories defined by MET-hrs/week as follows: vigorous: >17MET-hrs/week; moderate: >6.5 to ≤17 MET-hrs/week; and no/light: 0 to ≤6.5 MET-hrs/week.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.